Pharmaceuticals & Biotechnology Editor | 08/18/2011
Jan-Gunnar Gustafsson Vice President, Process Development and Manufacturing, Baau Therapeutics AB, speaks to Andrea Charles from Pharma IQ, about contract manufacturing strategy, mitigating risk and approaches to CMO selection from a small biotech perspective, at Pharma IQ's Global Pharmaceutical Contract Manufacturing Conference for Pharma and Bio in June 2011. Gustafsson also shares his insights on the challenges that you face when outsourcing from a small company and ...
To continue reading this story Click Here
RECOMMENDED
Digital Transformation in Pharma: Navigating CMO Partnerships and Supply Chain Resilience
2025-01-22
Sustainability and Inclusivity in Pharma Manufacturing: Insights from AstraZeneca’s People Hub
2024-12-11
Upcoming Events
Pharmaceutical Launch Excellence Summit
2 - 3 December, 2025
UK
Register Now |
View Agenda |
Learn More